Defunct Company
Total Trials
6
As Lead Sponsor
1
As Collaborator
5
Total Enrollment
538
NCT00057369
Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2001
Completion: Jun 30, 2003
NCT00037219
The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.
Role: Collaborator
Start: Aug 31, 2001
Completion: Nov 30, 2002
NCT00037206
A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).
Phase: Phase 2/3
Start: May 31, 2002
Completion: Feb 28, 2003
NCT00041704
The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)
Start: Aug 31, 2002
Completion: Aug 31, 2004
NCT00056368
The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis
Phase: Phase 3
Start: Mar 31, 2003
Completion: Oct 31, 2004
NCT00056381
Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17
Phase: Phase 1/2
Start: Jul 31, 2003
Completion: Jun 30, 2004